$14.71
0.634.47%
Pre-Market: 7:38 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for ARS Pharmaceuticals in recent months.
Browse guidance and forecast on all stocks.